+100
ื”ื•ืจื“ื•ืช
ืกื™ื•ื•ื’ ืชื•ื›ืŸ
ื›ื•ืœื
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš
ืฆื™ืœื•ื ืžืกืš

ืžื™ื“ืข ืขืœ ื”ืืคืœื™ืงืฆื™ื” ื”ื–ื•

ืžืขืงื‘ ืื—ืจ ื”ืกื™ืžืคื˜ื•ืžื™ื ื•ื”ื–ืจื™ืงื•ืช ืฉืœืš ื”ื•ื ื—ืœืง ื—ืฉื•ื‘ ืฉืœ ื˜ื™ืคื•ืœ ื‘ืืงืจื•ืžื’ืœื™ื” ืฉืœืš. ื•AcroTracker โ„ข ื™ื›ื•ืœ ืœืขื–ื•ืจ. โ€ข ืžืกืœื•ืœ ืื™ืš 5 ื”ืกื™ืžืคื˜ื•ืžื™ื ืฉืœ ืืงืจื•ืžื’ืœื™ื” (ื”ื–ืขื”, ื ืคื™ื—ื•ืช, ื›ืื‘ื™ ื”ืจืืฉ, ืขื™ื™ืคื•ืช, ื•ื›ืื‘ื™ ืคืจืงื™ื) ืžืฉืคื™ืขื™ื ืขืœื™ืš ื‘ื›ืœ ื™ื•ื โ€ข ืขืงื•ื‘ ืื—ืจ ื”ื–ืจื™ืงื•ืช ืฉืœืš ื›ื“ื™ ืœืขื–ื•ืจ ืœืš ื•ืืช ื”ืจื•ืคื ืฉืœืš ืœื–ื”ื•ืช ื“ืคื•ืกื™ื ืœื’ื‘ื™ ืžืชื™ ื•ืื™ืš ืืชื” ืžืชื™ื™ื—ืก ืœโ€ข ื™ืฉ ืฉื™ื—ื•ืช ื™ืขื™ืœื•ืช ื™ื•ืชืจ ืขื ื”ืจื•ืคื ืฉืœืš ืขืœ ื™ื“ื™ ืฉื™ืชื•ืฃ ื“ื™ื•ื•ื—ื™ ืกื™ืžืคื˜ื•ื ื•ื”ื–ืจืงื” ืœืš ืœื™ืฆื•ืจ ื”ื™ืฉืืจื• โ€ข ืขืœ ื’ื‘ื™ ื˜ื™ืคื•ืœื™ื ืขื ืชื–ื›ื•ืจื•ืช ืœื›ืืฉืจ ื”ื’ื™ืขื• ื–ืžืŸ ืœื”ื–ืจื™ืง AcroTracker ืœื ืืžื•ืจื” ืœืชืคื•ืก ืืช ืžืงื•ืžื• ืฉืœ ื”ื™ื™ืขื•ืฅ ืฉืœ ื”ืจื•ืคื ืฉืœืš. ืื ื ืฆื•ืจ ืงืฉืจ ืขื ืื•ืชื• ืื• ืื•ืชื” ืื ื™ืฉ ืœืš ืฉืืœื•ืช ื›ืœืฉื”ืŸ ืœื’ื‘ื™ ื˜ื™ืคื•ืœ. AcroTracker ืื™ื ื• ืžื™ื•ืขื“ ืœืจื™ืคื•ื™, ื˜ื™ืคื•ืœ, ื”ืžื‘ืงืฉื™ื ื˜ื™ืคื•ืœ ืœื ื™ื”ื•ืœ, ืื• ืื‘ื—ื•ืŸ ืžื—ืœื” ืกืคืฆื™ืคื™ืช, ื”ืคืจืขื”, ืื• ื›ืœ ืžืฆื‘ ื‘ืจื™ืื•ืชื™ ื”ื ื™ืชืŸ ืœื–ื™ื”ื•ื™ ืกืคืฆื™ืคื™.
ืขื“ื›ื•ืŸ ืื—ืจื•ืŸ ื‘ืชืืจื™ืš
12 ื‘ืคื‘ืจืณ 2025

ืื‘ื˜ื—ืช ื ืชื•ื ื™ื

ื›ื“ื™ ืœืฉืžื•ืจ ืขืœ ื”ื‘ื˜ื™ื—ื•ืช ืฆืจื™ืš ืงื•ื“ื ื›ืœ ืœื”ื‘ื™ืŸ ืื™ืš ื”ืžืคืชื—ื™ื ืื•ืกืคื™ื ื•ืžืฉืชืคื™ื ืืช ื”ื ืชื•ื ื™ื ืฉืœืš. ื ื•ื”ืœื™ ืคืจื˜ื™ื•ืช ื”ื ืชื•ื ื™ื ื•ืื‘ื˜ื—ืช ื”ื ืชื•ื ื™ื ืขืฉื•ื™ื™ื ืœื”ืฉืชื ื•ืช ื‘ื”ืชืื ืœืฉื™ืžื•ืฉ, ืœืื–ื•ืจ ื•ืœื’ื™ืœ ื”ืžืฉืชืžืฉ. ื”ืžืคืชื— ืกื™ืคืง ืืช ื”ืžื™ื“ืข ื”ื–ื” ื•ื”ื•ื ืขืฉื•ื™ ืœืขื“ื›ืŸ ืื•ืชื• ืžื“ื™ ืคืขื.
ื”ืืคืœื™ืงืฆื™ื” ื”ื–ืืช ืขืฉื•ื™ื” ืœืฉืชืฃ ืืช ืกื•ื’ื™ ื”ื ืชื•ื ื™ื ื”ืืœื” ืขื ืฆื“ื“ื™ื ืฉืœื™ืฉื™ื™ื
ืคืขื™ืœื•ืช ื‘ืืคืœื™ืงืฆื™ื•ืช
ื”ืืคืœื™ืงืฆื™ื” ื”ื–ืืช ืขืฉื•ื™ื” ืœืืกื•ืฃ ืืช ืกื•ื’ื™ ื”ื ืชื•ื ื™ื ื”ืืœื”
ื‘ืจื™ืื•ืช ื•ื›ื•ืฉืจ, ืงื‘ืฆื™ื ื•ืžืกืžื›ื™ื ื•ืคืขื™ืœื•ืช ื‘ืืคืœื™ืงืฆื™ื•ืช
ื”ื ืชื•ื ื™ื ืœื ืžื•ืฆืคื ื™ื
ืื™ ืืคืฉืจ ืœืžื—ื•ืง ืืช ื”ื ืชื•ื ื™ื

ืžื” ื—ื“ืฉ?

SDK update and support activity

ืชืžื™ื›ื” ื‘ืืคืœื™ืงืฆื™ื”

ืžื™ื“ืข ืขืœ ืžืคืชื—ื™ ื”ืืคืœื™ืงืฆื™ื”
Pfizer Inc.
appsupport@pfizer.com
66 Hudson Blvd E Fl 20 New York, NY 10001 United States
+1 855-574-6170

โ€ซืขื•ื“ ืžื‘ื™ืช Pfizer Inc.โ€Žโ€

ืืคืœื™ืงืฆื™ื•ืช ื“ื•ืžื•ืช